Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the diagnostic efficacy of CMC-001 in MR cholangiography in patients with suspected liver lesions
2005-004176-21Phase 2Completed
- Sponsor
- Ascelia Pharma
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of CMC 001 in Liver lesion (2 arms), sponsored by Ascelia Pharma. Primary endpoints: Diagnostic efficacy endpoints from MR images and Safety and tolerability. Started Apr 2006; status: completed.
02
Drugs
CMC 001
03
Conditions
Liver lesion
Beyond the preview
Go deeper on 2005-004176-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004176-21.